A Development Journey: Navigating the Challenges & Opportunities in Medical Interventions

Time: 8:30 am
day: Conf Day 1


  • Applying medications to life-threatening disease in premature infants including NEC and sepsis
  • Considering product quality for a highly vulnerable patient population with the ambition for IBP-9414 to become the world’s first approved medication for premature infants
  • Examining the data from the largest randomized controlled trial in the premature infants ever